Glaxo Looks To Bar FDA, Plea Evidence From Paxil Trial
Jurors in an upcoming trial over birth defects allegedly caused by the antidepressant Paxil must not be told about drugmaker GlaxoSmithKline's alleged campaign to defraud the FDA, about destruction of study...To view the full article, register now.
Already a subscriber? Click here to view full article